NEA Management Company’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Hold
3,775,615
0.17% 22
2025
Q4
$3.93M Hold
3,775,615
0.2% 22
2025
Q3
$5.32M Hold
3,775,615
0.29% 25
2025
Q2
$7.97M Hold
3,775,615
0.6% 22
2025
Q1
$12.7M Buy
3,775,615
+3,333,000
+753% +$13M 0.98% 18
2024
Q4
$1.55M Hold
442,615
0.09% 38
2024
Q3
$1M Hold
442,615
0.05% 40
2024
Q2
$1.22M Hold
442,615
0.09% 39
2024
Q1
$1.67M Hold
442,615
0.1% 39
2023
Q4
$2.92M Hold
442,615
0.19% 36
2023
Q3
$1.83M Hold
442,615
0.14% 39
2023
Q2
$2.78M Sell
442,615
-27,424
-6% -$268K 0.21% 38
2023
Q1
$4.92M Buy
470,039
+27,424
+6% +$427K 0.34% 36
2022
Q4
$5.35M Sell
442,615
-358
-0.1% -$8.73K 0.3% 38
2022
Q3
$8.23M Hold
442,973
0.41% 37
2022
Q2
$7.46M Buy
+442,973
New +$35.6M 0.38% 38

Other funds holding SNTI

NEA Management Company's SNTI Position: Q1 2026 in Review

NEA Management Company held its Senti Biosciences Holdings (SNTI) position steady in Q1 2026 at 3,775,615 shares worth $3.07M. The position accounts for 0.17% of the portfolio, ranked #22.

NEA Management Company first reported a position in SNTI in Q2 2022 and has held it in 16 quarters since. The position peaked at $12.7M in Q1 2025. 16 funds tracked by Wall St. Rank hold SNTI as of Q1 2026.

  • NEA Management Company held 3,775,615 shares of Senti Biosciences Holdings worth $3.07M as of Q1 2026.
  • NEA Management Company left its Senti Biosciences Holdings share count unchanged in Q1 2026.
  • Senti Biosciences Holdings made up 0.17% of NEA Management Company's portfolio in Q1 2026, its #22 holding.
  • NEA Management Company first reported a position in Senti Biosciences Holdings in Q2 2022 and has held it in 16 quarters since.
  • NEA Management Company's Senti Biosciences Holdings position peaked at $12.7M in Q1 2025.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q1 2026.

Based on NEA Management Company's 13F filing for Q1 2026, filed 15 May 2026.